Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Braz. j. med. biol. res ; 42(4): 358-367, Apr. 2009. graf
Artigo em Inglês | LILACS | ID: lil-509175

RESUMO

Lactobacillus delbrueckii UFV-H2b20 has been shown to increase clearance of bacteria injected into the blood of germ-free mice. Moreover, it induces the production of type 1 cytokines by human peripheral mononuclear cells. The objective of the present study was to investigate the production of inflammatory cytokines [interleukin-12 (IL-12 p40), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ)] triggered in vitro by live, heat-killed or lysozyme-treated L. delbrueckii UFV-H2b20 and in vivo by a live preparation. Germ-free, L. delbrueckii-monoassociated and lipopolysaccharide (LPS)-resistant C3H/HeJ mice were used as experimental models. UFV-H2b20 induced the production of IL-12 p40 and TNF-α by peritoneal cells and IFN-γ by spleen cells from germ-free or monoassociated Swiss/NIH mice and LPS-hyporesponsive mice (around 40 ng/mL for IL-12 p40, 200 pg/mL for TNF-α and 10 ng/mL for IFN-γ). Heat treatment of L. delbrueckii did not affect the production of these cytokines. Lysozyme treatment decreased IL-12 p40 production by peritoneal cells from C3H/HeJ mice, but did not affect TNF-α production by these cells or IFN-γ production by spleen cells from the same mouse strain. TNF-α production by peritoneal cells from Swiss/NIH L. delbrueckii-monoassociated mice was inhibited by lysozyme treatment. When testing IL-12 p40 and IFN-γ levels in sera from germ-free or monoassociated Swiss/NIH mice systemically challenged with Escherichia coli we observed that IL-12 p40 was produced at marginally higher levels by monoassociated mice than by germ-free mice (40 vs 60 ng/mL), but IFN-γ was produced earlier and at higher levels by monoassociated mice (monoassociated 4 and 14 ng/mL 4 and 8 h after infection, germfree 0 and 7.5 ng/mL at the same times). These results show that L. delbrueckii UFV-H2b20 stimulates the production of type 1 cytokines in vitro and in vivo, therefore suggesting...


Assuntos
Animais , Camundongos , Interferon gama/biossíntese , /biossíntese , Lactobacillus delbrueckii/imunologia , Macrófagos Peritoneais/imunologia , Fator de Necrose Tumoral alfa/biossíntese , Escherichia coli/imunologia , Vida Livre de Germes/imunologia , Macrófagos Peritoneais/microbiologia
2.
Mem. Inst. Oswaldo Cruz ; 96(1): 89-98, Jan. 2001. ilus, tab
Artigo em Inglês | LILACS | ID: lil-281634

RESUMO

In this study, we evaluated the immune response of patients suffering from cutaneous leishmaniasis treated with two distinct protocols. One group was treated with conventional chemotherapy using pentavalent antimonium salts and the other with immunochemotherapy where a vaccine against cutaneous leishmaniasis was combined with the antimonium salt. Our results show that, although no differences were observed in the necessary time for complete healing of the lesions between the two treatments, peripheral blood mononuclear cells from patients treated by chemotherapy showed smaller lymphoproliferative responses at the end of the treatment than those from patients in the immunochemotherapy group. Furthermore, IFN-gamma production was also different between the two groups. While cells from patients in the chemotherapy group produced more IFN-gamma at the end of treatment, a significant decrease in this cytokine production was associated with healing in the immunochemotherapy group. In addition, IL-10 production was also less intense in this latter group. Finally, an increase in CD8+ -IFN-gamma producing cells was detected in the chemotherapy group. Together these results point to an alternative treatment protocol where healing can be induced with a decreased production of a potentially toxic cytokine


Assuntos
Humanos , Masculino , Feminino , Adulto , Antiprotozoários/uso terapêutico , Interferon gama/biossíntese , Leishmaniose Cutânea/tratamento farmacológico , Leishmania/imunologia , Vacinas Protozoárias/uso terapêutico , Antígenos de Protozoários/imunologia , Antimônio/uso terapêutico , Citocinas/biossíntese , Método Duplo-Cego , Quimioterapia Combinada , Ensaio de Imunoadsorção Enzimática , Interleucina-10/biossíntese
3.
Rev. Inst. Med. Trop. Säo Paulo ; 40(6): 355-62, Nov.-Dec. 1998. ilus, tab
Artigo em Inglês | LILACS | ID: lil-228036

RESUMO

Camundongos isentos de germes (GF) e convencionais (CV) foram alimentados com racoes contendo 4,4, 13,2 ou 26,4 por cento de proteina nao ganharam peso durante quatro semanas, enquanto a racao deficiente em proteina nao afetou o crescimento dos camundongos GF. Apos quatro semanas nessas racoes, os camundongos foram inoculados com 5x10 elevado ao cubo tripomastigotos de Trypanosoma cruzi. A deficiencia em proteina afetou menos os camundongos GF do que os CV, segundo os seguintes parametros: ganho em peso, hemoglobina, niveis em proteina e albumina no plasma e conteudos em agua e proteina na carcassa. A infeccao com T. cruzi produziu um decrescimo significante nos niveis em hemoglobina, na contagem de celulas vermelhas sanguineas e nos conteudos em agua e proteina na carcaca. Este decrescimo foi mais acentuado nos camundongos GF...


Assuntos
Animais , Masculino , Camundongos , Doença de Chagas/dietoterapia , Proteínas Alimentares/uso terapêutico , Trypanosoma cruzi/isolamento & purificação , Trypanosoma cruzi/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA